Grace Kim

Bempegaldesleukin (BEMPEG; NKTR‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcoma

E. Kleinerman, J. Zalevsky, S. Kivimäe, 2020, International journal of cancer.

NKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse Potential

W. Rubas, D. Gauvin, J. Zalevsky, 2017, The Journal of Pharmacology and Experimental Therapeutics.

NKTR-358: A novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseases

J. Ritz, W. Rubas, C. Fanton, 2021, Journal of translational autoimmunity.

NKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse Potential

W. Rubas, D. Gauvin, J. Zalevsky, 2017, The Journal of Pharmacology and Experimental Therapeutics.